Author Archives: admin


Stem Cell Clinic > Articles by: admin

Inventiva reports 2024 Third Quarter Financial Information¹

By Global News Feed

Daix (France), New York City, (New York, United States), November 21, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today reported its cash position as of September 30, 2024 and its revenues for the first nine months of 2024.

Read more:
Inventiva reports 2024 Third Quarter Financial Information¹

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential…

By Global News Feed

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today expresses gratitude to shareholders for their unwavering support and trust in Tevogen Bio and its leadership. The commitment fuels the company’s determination to advance its mission of developing accessible, life-saving therapeutics.

Read this article:
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential...

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

By Global News Feed

Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and disease Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and disease

Read this article:
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval…

By Global News Feed

WOBURN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it has submitted a biologics license application (BLA) to the FDA for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of adult patients with advanced melanoma who have previously received an anti-PD1 containing regimen. The submission was made under the Accelerated Approval pathway. The Company also announced that the FDA has granted Breakthrough Therapy designation to RP1 in combination with nivolumab in the same setting.

Read the original here:
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval...

Korro to Participate in Upcoming Investor Conferences

By Global News Feed

CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, today announced that members of management will participate in the following investor conferences:

More:
Korro to Participate in Upcoming Investor Conferences

Lifecore Biomedical Hosts Virtual Investor Day

By Global News Feed

CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it hosted a virtual investor day prior to market open during which Lifecore’s senior management team discussed the company’s business and strategy for growth in the future, among other topics. A replay of the event is available via webcast and can be accessed by visiting the Events & Presentations section of Lifecore’s investor web page at: https://ir.lifecore.com/events-presentations.

Excerpt from:
Lifecore Biomedical Hosts Virtual Investor Day

High Haven Celebrates "Danksgiving" Cannabis Event with Green Wednesday and Holiday Deals Across Illinois Locations

By Global News Feed

WOODRIDGE, Ill., Nov. 21, 2024 (GLOBE NEWSWIRE) -- High Haven Dispensary, recognized as Illinois' top-rated cannabis retailer, invites cannabis enthusiasts to its 2nd Annual "Danksgiving" event on Wednesday, November 27, from 9 PM to midnight, at Hollywood Blvd Cinema in Woodridge. High Haven's "Danksgiving" combines entertainment, community, and cannabis culture in one exciting night. Attendees will enjoy cult classic films, live DJ sets, exclusive vendor pop-ups, premium swag, and more. Following the main event, High Haven will also offer enticing holiday deals through Green Wednesday, Black Friday, and Cyber Monday at all three dispensary locations in Normal, Darien, and Elgin.

More:
High Haven Celebrates "Danksgiving" Cannabis Event with Green Wednesday and Holiday Deals Across Illinois Locations

→←